Eris Lifesciences Limited — Others, 28-07-2025: Shareholders meeting

Eris Lifesciences held its 19th Annual General Meeting, where shareholders approved all key resolutions through e-voting. Key approvals included adopting the financial results for the latest fiscal year and appointing statutory, cost, and secretarial auditors. Shareholders also approved the re-appointment of Mr. Amit Bakshi as MD with 93.99% votes, Mr. Inderjeet Singh Negi as Whole-Time Director with 97.32%, and Mr. Kaushal Kamlesh Shah as Whole-Time Director with 98.50%. The resolution for Mr. Krishnakumar Vaidyanathan's re-appointment was withdrawn. This report confirms strong shareholder confidence in the company's financials and leadership.